Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now?
12:03pm, Thursday, 07'th Apr 2022
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Dear Biotech Investors: Novavax's Comparable Vaccine Matters
09:37am, Thursday, 07'th Apr 2022
Researchers compared Novavax's vaccine to three others on the market, offering a thorough glimpse of protection from boosters. The post Dear Biotech Investors: Novavax's Comparable Vaccine Matters app
The All-Weather Portfolio: The Good, The Bad, And The Ugly
06:06pm, Wednesday, 06'th Apr 2022 Seeking Alpha
The Financial Prophet's All-Weather Portfolio AWP delivered another solid quarter in Q1. Read the latest updates for the all-weather portfolio here.
4 Reasons You’re Not Making Money With Penny Stocks
02:04pm, Wednesday, 06'th Apr 2022 PennyStocks
How to make money with penny stocks.
The post 4 Reasons You’re Not Making Money With Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Don't Bet on New Highs for Novavax Stock
09:58am, Wednesday, 06'th Apr 2022
Investors would do well to avoid repeating the mistake of expecting moonshots in NVAX stock. The business may do better, but the stock won't.
3 COVID-19 Stocks With Monster Upside of Up to 355%, According to Wall Street
09:21am, Wednesday, 06'th Apr 2022 The Motley Fool
Select analysts foresee these coronavirus stocks rocketing higher by 246% to 355% over the next year.
What's Going On With Novavax Shares Today?
03:17pm, Tuesday, 05'th Apr 2022
Novavax Inc (NASDAQ: NVAX) shares are trading significantly lower Tuesday. According to data from Benzinga Pro, Tuesday's trading volume is in line with Novavax's average trading volume over a 100
Why Is Novavax (NVAX) Stock Down Today?
02:55pm, Tuesday, 05'th Apr 2022
Today, investors in Novavax and NVAX stock appear to be spooked by some key rhetoric from Dr. Anthony Fauci regarding vaccinations. The post Why Is Novavax (NVAX) Stock Down Today?
Novavax Has More Upside Ahead, as Covid-19 Shots Hit the Market
11:14am, Tuesday, 05'th Apr 2022
After Covid-19 vaccine delivery and regulatory woes, there is finally more upside than downside risks with NVAX stock. The post Novavax Has More Upside Ahead, as Covid-19 Shots Hit the Market appeared
What to Make of Novavax's Adolescent Covid-19 Vaccine Move
10:41am, Tuesday, 05'th Apr 2022
Novavax stock's foray in the adolescent Covid-19 vaccine market could pay dividends but investors should tread with caution at this time as risk remains. The post What to Make of Novavax's Adolescent
Novavax Stock Is Alluringly Attractive at This Stage
07:40am, Monday, 04'th Apr 2022
Novavax is close to securing FDA approval for its Covid-19 vaccine yet NVAX stock is down since the end of January. What gives?
10 Investor Questions About COVID-19, Answered
02:19pm, Sunday, 03'rd Apr 2022 Benzinga
The COVID-19 outbreak has finally subsided in the U.S., but biotech investors still have plenty of lingering questions about the virus and what to expect in the months and years ahead.
On Thursday, Ba
Novavax (NVAX) Seeks EU Nod for COVID-19 Vaccine in Kids
05:09pm, Friday, 01'st Apr 2022 Zacks Investment Research
Novavax (NVAX) seeks label expansion for its COVID-19 vaccine in adolescents aged 12-17 years in the European Union. Currently, the vaccine is authorized for use in adults.
How to Approach Trading Downtrodden Novavax Today
04:02pm, Friday, 01'st Apr 2022
There are obvious reasons to be bearish on NVAX stock's price chart, but a word to the wise would include the use of this type of put spread. The post How to Approach Trading Downtrodden Novavax Today
Novavax (NVAX) Seeks EU Nod for COVID-19 Vaccine in Kids
02:53pm, Friday, 01'st Apr 2022
Novavax (NVAX) seeks label expansion for its COVID-19 vaccine in adolescents aged 12-17 years in the European Union. Currently, the vaccine is authorized for use in adults.
